How to Source Fluticasone furoate + Vilanterol for Pharmaceutical Formulation

Fluticasone furoate + Vilanterol (Powder For Inhalation(DPI/MDI), 92 mcg Fluticasone furoate / 22 mcg Vilanterol; 184 mcg Fluticasone furoate / 22 mcg Vilanterol) is classified under Respiratory Disorder. It is therapeutically aligned with reference brands such as Breo Ellipta®(US), Relvar Ellipta® (EU). This guide highlights key sourcing factors buyers should consider when procuring high-quality Fluticasone furoate + Vilanterol for formulation, R&D, or bulk manufacturing.

Product Overview: Fluticasone furoate + Vilanterol, sold as Breo Ellipta® (U.S.) and Relvar Ellipta® (EU), is a once-daily inhalation therapy for asthma and COPD. It combines anti-inflammatory and bronchodilator action in strengths like 92/22 mcg and 184/22 mcg, delivered via the Ellipta® DPI. A top choice in respiratory care and pharma exports.

1. Regulatory Compliance & Documentation

Ensure suppliers provide:

• ✔ Valid DMF (Drug Master File)
• ✔ COA (Certificate of Analysis) for each batch
• ✔ GMP, ISO, or ICH Q7 compliance certificates

2. Purity, Grade & Specification Matching

Fluticasone furoate + Vilanterol must meet exact grade and purity for your dosage form:

• ✔ USP / EP / JP grade verification
• ✔ Particle size distribution check
• ✔ Residual solvent and heavy metal limits

3. Supplier Reliability & Audit History

• ✔ Positive past audit reports
• ✔ Pharma client references
• ✔ Years of proven API manufacturing experience

4. Commercial Terms: Pricing, MOQ & Flexibility

• ✔ Transparent pricing
• ✔ Pilot batch MOQ flexibility
• ✔ Volume-based discounts

5. Lead Time, Inventory & Logistics

Typical lead time for Fluticasone furoate + Vilanterol is 4–6 weeks.

• ✔ Emergency dispatch options
• ✔ Regional warehousing
• ✔ Special storage if needed

6. Formulation Support

• ✔ Technical datasheets
• ✔ Sample availability
• ✔ Stability study support

Conclusion

Sourcing Fluticasone furoate + Vilanterol is more than procurement—it’s a strategic partnership. With its powder for inhalation(dpi/mdi) form and 92 mcg Fluticasone furoate / 22 mcg Vilanterol; 184 mcg Fluticasone furoate / 22 mcg Vilanterol specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.

Frequently Asked Questions For Sourcing of Fluticasone furoate + Vilanterol